[2] Moss EL,Hollingworth J,Reynolds TM.The role of CA125 in clinical practice[J].J Clin Pathol,2005,58(3):308-312.
[2] Shih LM,Sokoll LJ,Chan DW.Ovarian Cancer[M]//Diamandis EP,Fritsche HA,Lilja H,et al.Tumor markers:physiology,pathobiology,technology,and clinical applications[M].USA:Am Assoc Clin Chem Inc,2002:239-252.
[3] Kirchhoff C,Habben I,Ivell R,et al.A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors[J].Biol Reprod,1999,45(2):350-357.
[4] Bingle L,Singleton V,Bingle CD.The putative ovarian tumour marker gene HE4(WFDC2),is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms[J].Oncogene,2002,21(17):2768-2773.
[5] Drapkin R,Von Horsten H,Lin Y,et al.Human epididymis protein 4(HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas[J].Cancer Res,2005,65(6):2162-2169.
[6] Galgano MT,Hampton GM,Frierson HF.Comprehensive analysis of HE4 expressiorn in normal and malignant human tissue[J].Modern Pathol,2006,19(6):847-853.
[7] Moore RG,Brown AK,Miller MC,et al.The use of multiple novel tumor biomarker for the detection of ovarian carcinoma in patients with a pelvic mass[J].Gynecol Oncol,2008,108(2):402-408.
[8] Moore RG,McMeekin DS,Brown AK,et al.A noval multiple marker bioassay utiliazing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass[J].Gynecol Oncol,2009,112(1):40-46.
[9] Bast RC Jr,Badgwell D,Lu Z,et al.New tumor markers:CA125 and beyond[J].Int J Gynecol Cancer,2005,15(3):274-281.
[10] 董丽,昌晓红,叶雪,等.血清人附睾分泌蛋白4和CA125水平检测在卵巢恶性肿瘤中的诊断价值[J].中华妇产科杂志,2008,43(12):931-936.
[11] Ni X,Zhang W,Huang KC,et al.Characterisation of human kallikrein 6/protease M expression in ovarian cancer[J].Br J Cancer,2004,91(4):725-731.
[12] Diamandis EP,Scorilas A,Fracchioli S.Human kallikrein 6(hK6):a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma[J].J Clin Oncol,2003,21(6):1035-1043.
[13] 吴文英,徐春琳.卵巢上皮性癌患者肿瘤组织和血清KLK6的表达及临床意义[J].中国肿瘤临床,2009,36(4):211-213.
[14] 胡成进,张芳,陈英剑,等.人组织型激肽释放酶6在卵巢上皮性肿瘤中的表达及其与临床病理特征和预后的关系[J].中华肿瘤杂志,2009,31(7):520-523.
[15] Koprowski H,Steplewski Z,Mitchell K,et al.Colorectal carcinoma antigens detected by hybridoma antibodies[J].Somatic Cell Genet,1979,5(6):957-971.
[16] Litvinov SV,Velders MP,Bakker HA.Ep-CAM,a hunman epithelial antigen is a homophilic cell-cell adhesion molecule[J].J Cell Biol,1994,12(5):437-446.
[17] Philip TH,Went MD.Frequent EPCAM protein expression in human carcinomas[J].Hum Pathol,2004,35(1):122-128.
[18] Abe H,Kuroki M,Imakiire T.Preparation of recombinant MK-1/Ep-CAM and establishment of an ELISA system for determining soluble MK-1/Ep-CAM levels in sera of cancer patients[J].J Immunol Methods,2002,270(2):227-233.
[19] Kim JH,HerLyn D,Wong KK.Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer[J].Clin Cancer Res,2003,9(13):4782-4791.
[20] 刘晓燕.应用组织芯片技术研究CA125和EPCAM联合检测卵巢癌的价值[J].中国免疫学杂志,2006,22(5):467-472.
[21] Di Paolo C,Willuda J,Kubetzko S,et al.A recombinant immunotoxin derived from a humanized epithelial cell adhesion molecule-specific single-chain antibody fragment has potent and selective antitumor activity[J].Clin Cancer Res,2003,9(7):2837-2848.
[22] Simon I,Zhuo S,Corral L,et al.B7-H4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer[J].Cancer Res,2006,66(3):1570-1575.
[23] Simon I,Katsaros D,Rigault de la Longrais I.B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression[J].Gynecol Oncol,2007,106(2):334-341.
[24] Prasad DV,Richards S,Mai XM,et al.B7S1,a novel B7 family member that negatively regulates T cell activation[J].Immunity,2003,18(6):863-873.
[25] Garg M,Chaurasiya D,Rana R,et al.Sperm-associated antigen 9,a novel cancer testis antigen,is a potential target for immunotherapy in epithelial ovarian cancer[J].Clin Cancer Res,2007,13(5):1421-1428.